The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCO 2016 | Why hematologists should use social media
Michael Thompson, MD, PhD of the Aurora Health Care, Milwaukee, WI discusses why hematologists should use social media. First Dr Thompson addresses some of the common reservations medical professionals might have about using social media. He then talks about its benefits, such as receiving highly curated information from other Twitter users, discussing opinions and influencing other people to affect change.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.
